Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $93.4M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 201.45B 25.2B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
Cara Therapeutics USD 46M 23M Jun/2025
Cassava Sciences USD 86M 55M Feb/2026
Eisai JPY 1.43T 119.2B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Geron USD 874M 24M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 684M 43M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025